Hemangioblastoma

A hemangioblastoma is a type of non-cancerous (benign) growth in the brain. It's a small tumor made of blood vessel-like structures. These tumors can sometimes be linked to a rare genetic condition called Von Hippel-Lindau disease. They often grow in the cerebellum, which is part of the brain at the back. People might notice symptoms like headaches or problems with balance, like dizziness or trouble walking.

Condition

What people with Hemangioblastoma report

Every report comes from a Lived member, sent anonymously.

Have you had Craniotomy for Hemangioblastoma?

NameHow it went

About Hemangioblastoma

What It Is

A hemangioblastoma is a slow-growing, noncancerous tumor made up of a dense tangle of small blood vessels. It forms in the central nervous system, most often in the cerebellum (the part of the brain at the back of the head that coordinates balance and movement), and less often in the brainstem, the spinal cord or the retina at the back of the eye. It does not spread to other parts of the body. Being benign does not make it harmless. These tumors often sit beside a fluid-filled cyst, and it is usually the cyst, not the tumor itself, that grows large enough to press on nearby tissue. In the cerebellum that can cause headaches, nausea, unsteadiness and clumsiness; in the spinal cord, numbness, weakness or pain; in the retina, blurred or lost vision. Hemangioblastomas are uncommon, making up less than 2% of tumors of the brain and spinal cord, and most are found in adults.

Causes & Risk Factors

Most hemangioblastomas, roughly 7 in 10, are sporadic: they appear on their own, as a single tumor, for no known reason. They are usually found in middle age, on average in the late 40s. The other 3 in 10 occur in people with von Hippel-Lindau disease (VHL), an inherited condition caused by a change in the VHL gene that normally helps keep cell growth in check. People with VHL tend to develop hemangioblastomas about 20 years earlier, often several over a lifetime, and they can also develop cysts and tumors in the kidneys, pancreas, adrenal glands and inner ear. VHL is usually passed from a parent, though some people are the first in their family to have it. Nothing a person does is known to cause or prevent a hemangioblastoma.

How It's Diagnosed

Diagnosis starts with symptoms and a neurological exam, followed by imaging. Magnetic resonance imaging (MRI) with contrast dye is the main test because it shows the whole brain and spinal cord in detail. A hemangioblastoma often has a typical look: a cyst with a small, brightly enhancing knot of tumor in its wall. When a tumor is removed, examining the tissue under a microscope confirms the diagnosis. Some people also have a high red blood cell count, because these tumors can produce a hormone that stimulates red cell production. An important part of the workup is asking whether VHL is involved. Genetic testing for VHL is recommended for people diagnosed with a hemangioblastoma before age 50, anyone with more than one hemangioblastoma or a retinal one, and anyone with a family history of VHL. If VHL is found, a full evaluation follows, including an eye exam, imaging of the abdomen and blood or urine tests, and relatives can be offered testing too.

Treatment Options

Treatment depends on where the tumor is, whether it causes symptoms and whether VHL is present. Surgery to remove the tumor is the standard treatment for one that is causing problems, and when the whole tumor is removed it is usually cured. In some cases the tumor's blood supply is blocked with a catheter procedure (embolization) before surgery to reduce bleeding. When surgery would be too risky, for example for some tumors in the brainstem or spinal cord, stereotactic radiosurgery (a precisely focused, high dose of radiation given without an incision) can stop many tumors from growing. Most studies of it come from people with VHL and follow results for about five years, so its very long-term effects are less well known. For adults with VHL whose brain or spinal hemangioblastomas need treatment but not immediate surgery, belzutifan (Welireg) is an option. It is a daily pill that blocks hypoxia-inducible factor 2 alpha (HIF-2 alpha), a protein that drives these tumors' growth when the VHL gene does not work. In its main study, most people's tumors and surrounding cysts shrank. It can harm a developing pregnancy and can make some hormonal birth control less effective, so a non-hormonal method is needed. Anemia (a low red blood cell count) is very common, and blood counts and oxygen levels are checked during treatment. It is not approved for hemangioblastomas that are not linked to VHL. Retinal hemangioblastomas are treated by eye specialists, usually with laser treatment or freezing (cryotherapy), ideally while they are still small.

What to Expect

For a single sporadic hemangioblastoma, the outlook after complete removal is generally good, and many people return to their usual activities. Recovery depends on the tumor's location: some people have lingering unsteadiness, numbness or weakness, especially if symptoms were present for a long time before surgery, and rehabilitation can help. Follow-up MRI scans check that the tumor has not come back. Hemangioblastomas grow unpredictably, often in spurts separated by long quiet periods. For that reason, a tumor that is not causing symptoms is often watched with regular scans rather than treated right away, since every treatment carries its own risks. For people with VHL, hemangioblastoma is a lifelong issue rather than a single event. New tumors can appear over many years, so care involves scheduled MRI scans, eye exams and screening of other organs, ideally coordinated by a team experienced in VHL. The aim is to treat tumors at the right moment, before they cause permanent damage but without unnecessary operations. Living with ongoing surveillance can be stressful, and VHL support organizations and genetic counseling can help individuals and families.

When to Seek Help

See a doctor about ongoing headaches, new problems with balance or coordination, numbness or weakness in the arms or legs, or vision changes such as floaters or a shadow in part of your vision. If you have a hemangioblastoma or VHL, tell your care team promptly about any new or returning symptoms, since they can mean a tumor or cyst is growing, even between scheduled scans. Get emergency care for a severe or rapidly worsening headache with repeated vomiting, drowsiness, confusion or a seizure, because these can mean pressure is building inside the skull from a tumor, cyst or bleeding.

Questions to Ask Your Doctor

  1. 1.Is this tumor causing my symptoms, and does it need treatment now or can it be watched?
  2. 2.Should I have genetic testing for von Hippel-Lindau disease, and what would a positive result mean for my family?
  3. 3.Can the whole tumor be removed safely, and what are the risks given where it is?
  4. 4.If surgery is not the best choice, how do radiosurgery or belzutifan compare for me?
  5. 5.How often will I need MRI scans or eye exams, and for how long?

Last reviewed • Oct 2026

Educational content, not medical advice.